Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modern-day Slavery in our Health Care System: An Advocacy Journey.
Panda P, Garg A. Panda P, et al. Among authors: garg a. Pediatrics. 2019 Oct;144(4):e20192370. doi: 10.1542/peds.2019-2370. Epub 2019 Sep 9. Pediatrics. 2019. PMID: 31501237
We asked writers to share experiences as physician advocates and were impressed with the broad variety of important topics submitted by trainees from around the country. This essay by Drs Panda and Garg highlights a critical issue facing children, human trafficking, …
We asked writers to share experiences as physician advocates and were impressed with the broad variety of important topics submitted by trai …
Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-Risk Classical Hodgkin Lymphoma.
Zhang Z, Zhang D, Guo W, Fenton K, Narayanan S, Jain S, Jiang J, Castellino SM, Kelly KM, Cole PD, Keller FG, Garg A, Chia YL. Zhang Z, et al. Among authors: garg a. Clin Cancer Res. 2024 May 29. doi: 10.1158/1078-0432.CCR-23-3655. Online ahead of print. Clin Cancer Res. 2024. PMID: 38810021
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, Giamarellos-Bourboulis EJ, Fujita H, Rolleri R, Joshi P, Dokhe P, Muller E, Peterson L, Madden C, Bari M, Zouboulis CC. Kimball AB, et al. Among authors: garg a. Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101-6. Online ahead of print. Lancet. 2024. PMID: 38795716
Recent advances in catalytic asymmetric synthesis.
Garg A, Rendina D, Bendale H, Akiyama T, Ojima I. Garg A, et al. Front Chem. 2024 May 9;12:1398397. doi: 10.3389/fchem.2024.1398397. eCollection 2024. Front Chem. 2024. PMID: 38783896 Free PMC article. Review.
4,268 results